A synthetic peptide for use as a blocking control in assays to test for specificity of HOXA9 antibody, Alternative Names: HOXA9 control peptide, HOXA9 antibody Blocking Peptide, Anti-HOXA9 Blocking Peptide, homeobox A9 Blocking Peptide, ABD-B Blocking Peptide, HOX1 Blocking Peptide, HOX1.7 Blocking Peptide, HOX1G Blocking Peptide, MGC1934 Blocking Peptide, HOXA9, HOXA-9, HOXA 9, HOXA-9 Blocking Peptide, HOXA 9 Blocking Peptide
HOXA9
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
HOXA9
(Homeobox A9 (HOXA9))
Hintergrund
In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. HOXA9 gene is part of the A cluster on chromosome 7 and the protein is a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. This gene is highly similar to the abdominal-B (Abd-B) gene of Drosophila.